Compare RSSS & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RSSS | ALPS |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.2M | 66.6M |
| IPO Year | 2008 | 2024 |
| Metric | RSSS | ALPS |
|---|---|---|
| Price | $1.85 | $0.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.83 | N/A |
| AVG Volume (30 Days) | ★ 30.5K | 26.2K |
| Earning Date | 11-12-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $28,793,922.00 | N/A |
| Revenue This Year | $1.40 | N/A |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $20.78 | ★ N/A |
| Revenue Growth | ★ 2.77 | N/A |
| 52 Week Low | $1.78 | $0.23 |
| 52 Week High | $3.38 | $1.72 |
| Indicator | RSSS | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 28.68 | 31.67 |
| Support Level | N/A | $0.23 |
| Resistance Level | $2.34 | $0.44 |
| Average True Range (ATR) | 0.07 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 21.43 | 13.33 |
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from the cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.